Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and dermatology innovations, today announced that the Brazilian Health Regulatory Agency (ANVISA) has approved Winlevi® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback